Aalborg University Hospital

Sperimentazioni cliniche corrispondenti

Studio sull’accuratezza diagnostica di 68Ga-FAPI-46 e Fludeoxyglucose (18F) in pazienti con cancro ovarico

Arruolamento concluso

2 1 1 1
Malattie in studio:
- Cancro dell’ovaio
Farmaci in studio:
- Fludeoxyglucose (18F)
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Studio sull’accuratezza diagnostica di 68Ga-FAPI-46 e Fludeoxyglucose (18F) in pazienti con cancro gastrico e della giunzione gastroesofagea

Arruolamento concluso

2 1 1 1
Malattie in studio:
- Cancro dello stomaco
Farmaci in studio:
- Fludeoxyglucose (18F)
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate